- How are we ensuring under-served patient populations voices are considered in trial format?
- Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.
health equity
clinical trials

Brittany Gerald
Associate Director, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)
Moderna

Benjamin Young
Senior Global Medical Director
ViiV Healthcare

Sandra Amaro
Head of Clinical Trial Diversity
Pfizer